Buy a few shares of AMBS under a dime.
Company has a second "orphan indication" for MANF in hand. The speculation is that it's in the field of diabetes and Novartis and NovoNordisk are in development talks with the company currently.
Validation data from Becton Dickinson for "LymPro" which is the company's diagnostic test to detect early stage Alzheimer's is expected soon. $500,000,000 annual market.
Current fair value is .40. Due diligence.
Follow the company on Twitter: @AmarantusBio .... 8,472 followers
Gerald should be releasing the news soon. Monday?
Rumor is that the next "orphan indication" is in the field of diabetes.
GDNF was purchased by Amgen for about $250,000,000. MANF is showing greater potential.
The applicable bird reference here is the one related to "eating crow".
Visit the company's website. Find the link to this week's Rodman & Renshaw presentation. Most recent overview.
Follow the company on Twitter: @AmarantusBio .... 8,465 followers.... Checkout who they are.
Buy some shares today at under seven cents and hold them for six months. Realistic price in six months is .30 or higher. Downside is a penny.
If the only information you had about the company was the conference call and someone asked you what market cap would you place on the company wouldn't you think that the market cap would be in excess of $100M currently?
Gerald has already stated that he has a second "orphan indication" for MANF. There is speculation that it is related to the field of diabetes which is a huge and growing market especially in the United States.
The current share price is a gift.
Visit the company's website and listen to yesterday's presentation at the Rodman & Renshaw Investor's Conference.
"AMBS" - Currently trading under a dime.
Buy a few shares under seven cents today. Becton Dickinson/LymPro news due out at any time.
Second "orphan indication" for the company's MANF drug is rumored to be in the field of diabetes. Novartis and Novo Nordisk are possible parties of interest.
Follow the company on Twitter: @AmarantusBio .... 8,467 followers
Recoup some GSS losses. Get in today under eight cents.
Listen to yesterday's Rodman & Renshaw presentation. Link is under the company's headline news on Yahoo.
Most undervalued stock in the market.
Follow the company on Twitter: @AmarantusBio .... 8,466 followers